This guide compares orlistat and the Wegovy pill at the level of how they work and what is available, with orlistat licensed and available today and the Wegovy pill not yet UK-licensed. It does not compare their efficacy as UK fact, because the pill has no UK results picture yet. It is grounded in the UK-licensed product information and is general information.
Two oral options, two different mechanisms
The headline is that orlistat and the Wegovy pill are both taken by mouth but work in entirely different ways51. Orlistat acts in the gut, reducing how much dietary fat is absorbed; the Wegovy pill is oral semaglutide, which acts on appetite51.
So they are not two versions of the same kind of medicine 5. One changes how your body handles the fat you eat; the other changes how hungry you feel and how much you eat in the first place 51.
That difference shapes everything else, from side effects to how they are taken, and it is the key thing to understand before comparing them 51. The rest of this guide builds on it 5.
How orlistat works
Orlistat is a lipase inhibitor: it blocks some of the enzymes that digest dietary fat, so a portion of the fat you eat passes through undigested rather than being absorbed 5. It is taken with meals and used alongside a reduced-calorie, lower-fat diet 5.
Because it acts on fat in the gut, its characteristic side effects are gastrointestinal and fat-related, and they are largely influenced by how much fat is in the diet 5. A lower-fat diet, which is the diet it is meant to accompany, keeps these milder 5.
Orlistat is licensed and available in the UK now5. Our guide on orlistat explains it in more detail, and it can be discussed with a clinician as a current option 5.
How the Wegovy pill is meant to work
The Wegovy pill is oral semaglutide, designed to act on appetite regulation, reducing energy intake and hunger, the same mechanism as the Wegovy injection 1. So it works on the appetite side rather than the fat-absorption side 1.
It is not yet licensed in the UK, so this guide makes no efficacy, dose or safety claims for it as UK fact 14. Its UK details would come from its licence once approved 4.
What can be said for the comparison is the mechanism contrast: appetite (Wegovy pill) versus fat absorption (orlistat) 15. That is a genuine, in-corpus difference even while the pill itself remains under review 1.
Want to know when the Wegovy pill (oral semaglutide) becomes available in the UK? It is not yet licensed here, but you can join the waitlist to be notified, and explore the licensed options with a Cloud Pharmacy clinician in the meantime.
Availability: one is here now, one is not
The decisive practical difference is availability 54. Orlistat is licensed and available in the UK today; the Wegovy pill is not yet UK-licensed54. So for anyone choosing now, orlistat is a real oral option while the pill is not 5.
That makes the comparison partly forward-looking on the pill's side 4. Weighing 'Wegovy pill versus orlistat' as a present decision really means weighing orlistat against the other licensed options that exist now 51.
Any 'Wegovy pill' offered before UK licensing should be treated as a warning sign, given the NHS warning about fake weight-loss medicines 2. Genuine availability would come through registered pharmacies once it is licensed 24.
Why we don't compare their effectiveness
This guide does not compare the effectiveness of orlistat and the Wegovy pill as UK fact 4. Orlistat has a UK results picture from its licence; the pill does not yet, so a head-to-head efficacy claim would go beyond UK sources 54.
What can be said is that they work differently, so they suit different people and situations, and effectiveness is only one factor alongside how each is taken, its side effects and whether it fits your life 51. A clinician can weigh these for you 2.
Once the Wegovy pill has a UK licence and results picture, a more direct comparison would be possible 4. Until then, this guide compares mechanism and availability, which is the honest basis 54.
Which might suit you, and what to do now
Choosing between oral options is a clinical decision based on how each works, side effects, your diet and preferences, and your eligibility, made with a prescriber 51. There is no single 'best' oral option; the right one depends on you 5.
For now, orlistat is an available oral option to discuss with a clinician, and the other licensed weight-management medicines are available too 51. A proper assessment can establish what suits you today 2.
If it is specifically the Wegovy pill you want, you can join the waitlist to be notified when it is available, while considering the licensed options in the meantime 42. Our guide on choosing a weight-loss treatment sets the licensed options side by side 1.
Side effects and how each is taken
The two options differ in their side effects in ways that follow directly from how they work 51. Orlistat's characteristic effects are gastrointestinal and fat-related, such as changes to bowel habits, and they are largely driven by how much fat is in the diet, so a lower-fat diet keeps them milder 5.
Semaglutide's common side effects, by contrast, are gastrointestinal effects linked to appetite and digestion, such as nausea, typically most noticeable early and around dose increases 1. So the kinds of side effects people experience can feel quite different between the two 51.
They are also taken differently 5. Orlistat is taken with meals (and a dose can be omitted if a meal has no fat), whereas an oral semaglutide is expected to need careful administration for absorption, with its exact rules coming from the pill's UK product information once licensed 514.
Neither pattern is automatically easier; they suit different people and routines 5. Part of choosing between oral options is thinking about which side-effect profile and which way of taking the medicine fits your life, which a clinician can help you weigh 52.
Different tools for different situations
Because they work so differently, orlistat and an oral semaglutide are best thought of as different tools rather than direct rivals 51. One reduces fat absorption and pairs closely with a lower-fat diet; the other works on appetite to make eating less more achievable 51.
That means the 'better' option genuinely depends on the person: their eating patterns, their health, what they can tolerate, and their preferences 51. A medicine that suits one person's situation may not suit another's, which is why this is a clinical decision rather than a ranking 5.
It also means that comparing them purely on a headline effectiveness figure would miss the point, especially as the Wegovy pill has no UK results picture yet 54. Fit, tolerability and how each works matter at least as much as any single number 51.
So the practical approach is to discuss your circumstances with a clinician, consider orlistat and the other licensed options that are available now, and join the Wegovy pill waitlist if the pill is specifically what you want for the future 542.
One practical advantage worth noting is that orlistat is genuinely available today, so it is something you can actually act on rather than wait for 5. For someone who wants to start an oral option now, that availability is itself a meaningful point in its favour, regardless of how the pill eventually compares 54.
Ultimately the comparison is less 'which is better' and more 'which is right for you, and what can you start now', a question best answered with a clinician who can take your full picture into account 512.
It also helps to remember that an oral medicine is only useful if it fits your eating patterns and routine 5. Orlistat works best for someone willing to follow a lower-fat diet, since that is both how it works and how its side effects stay mild, whereas an appetite-acting medicine suits someone whose challenge is hunger and portion control 51. Matching the medicine to the problem is a large part of getting a good result 5.
So when the Wegovy pill does arrive, the useful comparison will not be a simple league table but a question of which approach, fat absorption or appetite, fits your situation, alongside the licensed options that already exist 514. A clinician can help you make that judgement when the time comes 52. In the meantime, joining the waitlist keeps you informed without committing to anything or relying on an unlicensed source 42.
It is also worth being realistic that no oral option is a substitute for the diet and activity changes that underpin weight management 51. Orlistat is explicitly used alongside a reduced-calorie, lower-fat diet, and semaglutide is used alongside a reduced-calorie diet and increased activity, so whichever you consider, the lifestyle side remains part of the picture rather than something the medicine removes 51.
Frequently asked questions
How is the Wegovy pill different from orlistat?
They work in completely different ways: orlistat blocks some dietary fat from being absorbed in the gut, while the Wegovy pill (oral semaglutide) acts on appetite 51. Orlistat is available now; the Wegovy pill is not yet UK-licensed 54.Is orlistat available now?
Yes, orlistat is licensed and available in the UK and can be discussed with a clinician as a current oral option 5. The Wegovy pill, by contrast, is not yet UK-licensed 4.Which works better, orlistat or the Wegovy pill?
This guide does not compare their efficacy as UK fact, because the pill has no UK results picture yet 54. They work differently, so they suit different people; a clinician can weigh the options for you 52.Do they have similar side effects?
No. Orlistat's are mainly gastrointestinal and fat-related, influenced by dietary fat 5, while semaglutide's are mainly gastrointestinal linked to appetite and digestion 1. The pill's specific profile would come from its UK licence 4.Can I get the Wegovy pill instead of orlistat now?
No. Orlistat is available now, but the Wegovy pill is not yet UK-licensed 54. Any 'Wegovy pill' offered now is a warning sign, given the NHS warning about fake weight-loss medicines 2.What should I do if I want the Wegovy pill?
Join the waitlist to be notified when it is available, and consider the licensed options, including orlistat, with a clinician in the meantime 42. A proper assessment can establish what suits you now 2.Your next step
Orlistat and the Wegovy pill are both oral, but they work in completely different ways: orlistat blocks some dietary fat from being absorbed in the gut, while the Wegovy pill (oral semaglutide) acts on appetite. That difference shapes their side effects and how they are taken, and it is the key thing to understand before comparing them.
The decisive practical point is that orlistat is licensed and available in the UK now, while the Wegovy pill is not yet UK-licensed, so a present-day choice is really between orlistat and the other licensed options. This guide does not compare their efficacy as UK fact, because the pill has no UK results picture yet. Choosing an oral option is a clinical decision made with a prescriber; if you specifically want the Wegovy pill, join the waitlist to be notified when it is available and consider the licensed options in the meantime.
Disclaimer
This guide is for general information only and does not constitute medical advice, diagnosis or treatment. The information here describes general clinical context based on UK regulatory sources cited above; it is not a recommendation for any specific medicine or treatment, which can only be made by a prescriber following individual assessment.
If you are considering treatment, speak to your GP or pharmacist, or arrange a consultation with a Cloud Pharmacy clinician. Prescription-only medicines are issued only after clinical assessment and where appropriate.
If you experience side effects from any medicine, you can report them through the Yellow Card scheme at yellowcard.mhra.gov.uk.
References
- Wegovy SmPC 4.1/5.1 (semaglutide; appetite-regulation mechanism; licensed weight-management INJECTION; used to describe the Wegovy pill's molecule, NOT to assert the pill's efficacy)
- Semaglutide (registered pharmacy; some websites sell fake weight-loss medicines; assessment; general framing)
- General UK framing; Wegovy pill not UK-licensed (June 2026); no pill efficacy/dose asserted; waitlist route
- Xenical (orlistat) SmPC 4.1/4.2/4.8/5.1 (lipase inhibitor; blocks absorption of some dietary fat; taken with meals alongside reduced-calorie lower-fat diet; GI/fat-related side effects; licensed and available)
